The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EORTC CLTF 2021 | Multimarker approach to CTC analysis in CTCL
Maarten Vermeer, MD, PhD, Leiden University Medical Center, Leiden, Netherlands, gives an overview of the multimarker approach to biomarker research and its role in the quantification of circulating tumor cells (CTCs) for diagnosis and treatment-response analysis in cutaneous T-cell lymphoma (CTCL). This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
